Crystal's Coder Hub💉 CPT 95874 — Needle Electromyography for Guidance in Conjunction With Chemodenervation
Quick Reference
wRVU: ~0.50 (verify CMS MPFS 2026) | Global Period: ZZZ (Add-on — inherits global period of primary chemodenervation code) | Assistant Payable: ❌ No | Bilateral Indicator: 0 | PC/TC Split: ✅ Yes — modifier -26 / -TC applicable
📋 Clinical Description
CPT 95874 is an add-on code that describes needle electromyography (EMG) performed specifically to guide needle placement during a chemodenervation injection. The clinician inserts a recording needle electrode into the target muscle, uses real-time EMG signal output (auditory or visual) to confirm the needle is positioned correctly within the motor end-plate zone, and then proceeds with chemodenervation agent injection. This code is reported in addition to the primary chemodenervation CPT code — it cannot be reported as a standalone code and must always be linked to a corresponding primary procedure code such as 64642, 64644, 64646, 64616, or another applicable chemodenervation code.
Chemodenervation involves injecting a neurotoxin (most commonly onabotulinumtoxinA/Botox®, incobotulinumtoxinA/Xeomin®, abobotulinumtoxinA/Dysport®, or rimabotulinumtoxinB/Myobloc®) into a motor nerve-muscle junction to temporarily reduce or eliminate abnormal muscle contraction. The neurotoxin blocks acetylcholine release at the neuromuscular junction, causing temporary paralysis or weakening of the treated muscle — the primary goal being reduction of dystonia, spasticity, or other hyperkinetic movement disorders. EMG guidance improves injection accuracy by confirming target muscle activity, particularly in deep or anatomically complex muscles where surface landmarks are insufficient.
CPT 95874 may be performed in the following clinical contexts:
- Cervical dystonia / spasmodic torticollis — EMG guidance directs the needle into the specific dystonic neck muscles (e.g., sternocleidomastoid, splenius capitis, trapezius) identified by involuntary contraction; reported with 64616 as the primary code
- Upper or lower limb spasticity — EMG guidance used during extremity chemodenervation to localize the motor point in deep muscles (e.g., tibialis posterior, flexor digitorum profundus); reported with 64642, 64643, 64644, or 64645 as the primary code
- Trunk muscle spasticity or dystonia — EMG guidance for trunk chemodenervation in paraspinal or abdominal muscles; reported with 64646 or 64647 as the primary code
- Blepharospasm or facial dystonia — EMG guidance for periorbital or facial muscle injections; reported with 64612 as the primary code
- Spasticity secondary to neurological injury (TBI, stroke, SCI, MS, CP) — EMG guidance used when spastic muscles are difficult to palpate or when precise motor point localization is required for optimal dosing of the chemodenervation agent
🔬 Anatomical & Procedural Considerations
| Guidance Technique | Mechanism | Key Notes / Coding Impact |
|---|---|---|
| Needle EMG (95874) | Recording needle inserted into target muscle; spontaneous motor unit potentials or voluntary activation signals confirm correct needle placement in motor end-plate zone | Most commonly used for deep muscles (e.g., tibialis posterior, subscapularis, iliopsoas); confirms active target muscle; generates EMG tracing — document in procedure note |
| Electrical Stimulation Guidance (95873) | Low-level electrical current delivered through the injection needle to stimulate the target nerve/muscle; visible or palpable muscle twitch confirms proximity to motor end plate | Alternative to 95874; uses different equipment; do NOT report 95874 and 95873 together for the same chemodenervation code — only one guidance code per corresponding chemodenervation code |
| Ultrasound Guidance (77002 / 76942) | Real-time ultrasound image used to visualize needle tip placement in the muscle | Ultrasound guidance for chemodenervation is NOT separately billable with 95874 — only one guidance modality can be billed per chemodenervation procedure; document which modality was used |
Clinical Pearl
The single most important documentation element for defending 95874 on audit is the procedure note’s explicit statement that: (1) needle EMG guidance was performed, (2) the specific muscle(s) targeted by EMG, and (3) EMG activity confirmed correct needle placement prior to injection. A note that simply states “Botox injected with EMG guidance” is insufficient — the note should describe the EMG signal observed (e.g., “needle EMG confirmed active motor unit potentials in the right tibialis posterior before injection”). This level of detail is what distinguishes a medically necessary, properly documented EMG-guided chemodenervation from a bare chemodenervation claim.
✅ Procedure Includes
- Pre-procedure identification of target muscle(s) and EMG electrode/needle selection
- Insertion of the recording needle electrode into the target muscle
- Real-time acquisition and interpretation of EMG signal (spontaneous or volitional motor unit potentials) to confirm correct intramuscular needle placement
- Repositioning of the needle under continued EMG monitoring if initial placement is suboptimal
- Confirmation of motor end-plate zone localization via characteristic EMG signal before the chemodenervation agent is injected
- Documentation of EMG signal findings, muscles targeted, and confirmation of guidance in the procedure note
❌ Excludes / Do Not Report Together
| Code | Description | Relationship to 95874 |
|---|---|---|
| 95873 | Electrical stimulation for guidance in conjunction with chemodenervation (add-on) | Mutually exclusive with 95874 for the same chemodenervation code — CPT instructs: do NOT report more than one guidance code (95873 or 95874) per corresponding chemodenervation code; choose one modality |
| 64617 | Chemodenervation of larynx, unilateral, percutaneous, includes guidance by needle EMG when performed | EMG guidance is bundled into 64617 — do NOT separately report 95874 (or 95873) when the primary code is 64617; guidance is included in the descriptor |
| 95860-95870 | Needle EMG, diagnostic (various extremity/paraspinal configurations) | Diagnostic EMG studies are NOT the same as EMG guidance; if a full diagnostic EMG study is performed on a separate indication at the same session, it may be separately reportable with modifier -59 — but this is rare and must be clearly documented as a distinct diagnostic study |
| 77002 | Fluoroscopic guidance, needle placement | Fluoroscopic guidance is not applicable to chemodenervation in neuromuscular settings — do not cross-report imaging guidance codes with 95874 |
| E/M codes (992xx) | Office visit, any level | Separately reportable only when modifier -25 is appended to the E/M code, documenting a significant, separately identifiable E/M service beyond the routine pre-injection assessment |
Bundling Alert — Global Period is ZZZ, Not 000
Because 95874 is a ZZZ add-on code, its global period is determined by the primary chemodenervation code it accompanies. Most chemodenervation codes (64612, 64616, 64642-64647) carry a 000 (same-day) global period, meaning no post-procedure follow-up visits are bundled — each subsequent visit is separately billable. However, the CPT instruction that only one unit of 95874 is reported per corresponding chemodenervation code (not per muscle, not per injection site) is the most common source of overbilling audits in this code family. If four extremity chemodenervation codes are reported (64642 + 64643 + 64644 + 64645), then up to four units of 95874 may be reported — one per chemodenervation code — but not more.
🌳 Code Tree — Medicine: Neurology / Neuromuscular — EMG Guidance & Chemodenervation
Medicine: Neuromuscular Procedures — Guidance Add-Ons
│
├── +95873 Electrical stimulation guidance for chemodenervation (add-on) (Global: ZZZ)
├── ▶▶ +95874 ◀◀ Needle EMG guidance for chemodenervation (add-on) ← YOU ARE HERE (Global: ZZZ)
│
Primary Chemodenervation Codes (must be reported alongside 95874)
│
├── 64612 Chemodenervation, muscle(s); muscle(s) innervated by facial nerve, unilateral (e.g., for blepharospasm, hemifacial spasm) (Global: 010)
├── 64615 Chemodenervation, muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (e.g., for chronic migraine) (Global: 010)
├── 64616 Chemodenervation, neck muscle(s), excluding larynx, unilateral (e.g., cervical dystonia) (Global: 010)
├── 64617 Chemodenervation, larynx, unilateral, percutaneous (includes EMG guidance when performed) — ⚠️ do NOT add 95874 (Global: 010)
├── 64642 Chemodenervation, one extremity; 1-4 muscle(s) (Global: 010)
├── +64643 Chemodenervation, each additional extremity, 1-4 muscle(s) (add-on) (Global: ZZZ)
├── 64644 Chemodenervation, one extremity; 5 or more muscle(s) (Global: 010)
├── +64645 Chemodenervation, each additional extremity, 5 or more muscle(s) (add-on) (Global: ZZZ)
├── 64646 Chemodenervation, trunk muscle(s); 1-5 muscle(s) (Global: 010)
└── 64647 Chemodenervation, trunk muscle(s); 6 or more muscle(s) (Global: 010)
💰 RVU & Reimbursement Profile
| Component | Value |
|---|---|
| Work RVU (wRVU) | ~0.50 (verify against CMS MPFS 2026 RVU file for exact value) |
| Global Period | ZZZ — Add-on code; global period inherits from primary chemodenervation procedure |
| Bilateral Indicator | 0 — Not independently bilateral; laterality managed through primary chemodenervation code modifier (RT/LT or -50) |
| Assistant Surgeon | ❌ Not payable |
| Co-Surgeon | ❌ Not applicable |
| Team Surgery | ❌ Not applicable |
| PC/TC Split | ✅ Yes — Indicator 1; modifier -26 for professional component (interpretation/guidance), -TC for technical component (EMG equipment/needle) |
| Modifier -51 Exempt | ✅ Yes — Add-on codes are inherently exempt from the multiple procedure reduction |
| Anesthesia | Local at injection site; no separate anesthesia billing expected |
PC/TC Split — Who Bills What
When the clinician performing the chemodenervation owns and operates the EMG equipment, the full (global) fee for 95874 is billed — no modifier needed. When the clinician performs the guidance interpretation but does not own the EMG equipment (e.g., hospital-owned machine in an outpatient clinic), bill 95874-26 for the professional component only. The facility or equipment owner bills 95874-TC. Per some MAC jurisdictions, billing only the -26 component may reduce reimbursement to approximately one-third of the full global fee — verify with your specific MAC’s fee schedule.
🏷️ Modifier Reference
| Modifier | Name | When to Apply |
|---|---|---|
| -26 | Professional Component | Clinician performing EMG guidance does not own the EMG equipment; bills for interpretation and guidance supervision only |
| -TC | Technical Component | Facility or entity billing for EMG equipment and supplies only (not the physician guidance interpretation) |
| -59 | Distinct Procedural Service | When payer inappropriately bundles 95874 with the primary chemodenervation code; documents that guidance is a separately identifiable, distinct service |
| -XU | Unusual Non-Overlapping Service | Alternative to -59 per payer or MAC preference; use when EMG guidance is documented as a service that does not overlap with the chemodenervation injection itself |
| -52 | Reduced Services | EMG guidance partially performed or abandoned before injection — document reason in procedure note |
| -53 | Discontinued Procedure | EMG guidance stopped due to patient safety concern before chemodenervation could proceed |
Do NOT Append -51 to 95874
🩺 Common ICD-10-CM Pairings
Dystonia — Primary Chemodenervation Indications
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G24.3 | Spasmodic torticollis (cervical dystonia) | ❌ No | Most common indication for 64616 + 95874; link G24.3 to the chemodenervation code and the EMG guidance add-on |
| G24.5 | Blepharospasm | ❌ No | Pairs with 64612 as primary; 95874 separately reportable for EMG-guided orbicularis oculi injection |
| G24.1 | Genetic torsion dystonia | ❌ No | Use for hereditary or idiopathic generalized dystonia; specify site with additional codes as needed |
| G24.8 | Other dystonia | ❌ No | Use when dystonia does not map to a more specific G24.x code; query provider for specificity when possible |
Spasticity — Neurological Injury and Disease
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| G81.11 | Spastic hemiplegia affecting right dominant side | ✅ HCC 103 | Pairs with 64642/64644 + 95874 for upper extremity injection; link hemiplegia code to the procedure |
| G81.12 | Spastic hemiplegia affecting left dominant side | ✅ HCC 103 | Left-side equivalent; confirm dominant vs. non-dominant from documentation |
| G80.0 | Spastic quadriplegic cerebral palsy | ✅ HCC 103 | Common pediatric indication; up to 4 extremity chemodenervation codes + corresponding 95874 units possible |
| G80.1 | Spastic diplegic cerebral palsy | ✅ HCC 103 | Lower extremity spasticity most common (e.g., gastrocnemius, tibialis posterior) |
| G35 | Multiple sclerosis | ✅ HCC 77 | MS-related spasticity; 95874 guides injection into spastic extremity muscles; link G35.A to the procedure |
| G82.51 | Quadriplegia, C1-C4, complete | ✅ HCC 70 | SCI-related spasticity; multiple extremity chemodenervation codes common |
Underlying Etiology / Sequela Codes
| ICD-10 Code | Description | HCC? | Clinical Notes |
|---|---|---|---|
| I69.351 | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side | ✅ HCC 103 | Post-stroke upper motor neuron spasticity — report as additional diagnosis to support medical necessity; clarify dominant vs. non-dominant in documentation |
| I69.352 | Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side | ✅ HCC 103 | Left dominant side post-stroke equivalent |
| S14.125S | Central cord syndrome at C5 level of cervical spinal cord, sequela | ✅ HCC 70 | SCI sequela driving spasticity; report as additional code supporting medical necessity for repeated chemodenervation |
| G43.711 | Chronic migraine with aura, intractable | ❌ No | Links specifically to onabotulinumtoxinA (Botox®) for chronic migraine prophylaxis per PREEMPT protocol; note that 95874 is NOT typically used with 64615 for migraine — injection sites are scalp/neck surface muscles and EMG guidance is not standard |
Coding Specificity Reminder
The ICD-10-CM diagnosis code linked to the chemodenervation CPT (and the corresponding 95874 add-on) must reflect the specific neurological condition driving spasticity or dystonia — not just “muscle spasm” (R25.2) unless no underlying etiology has been documented. The most commonly missed specificity axis is laterality and dominant vs. non-dominant side for hemiplegia codes (G81.x1 vs. G81.x2). Query the provider when the record documents post-stroke spasticity without specifying dominant vs. non-dominant side — this single detail changes the ICD-10-CM code and is required for accurate HCC capture.
🏥 MS-DRG Considerations (Inpatient)
Inpatient Coding Reminder
CPT 95874 is performed primarily in the outpatient office or ASC setting. There are no routine MS-DRG assignments for this procedure — inpatient admission for chemodenervation with EMG guidance would not be supported by most payers or utilization review bodies as medically necessary for the procedure itself. If a patient is admitted for an underlying neurological condition (e.g., acute MS exacerbation, TBI rehabilitation) and also receives chemodenervation with EMG guidance during the stay, the ICD-10-PCS section handles the inpatient facility coding. The CPT 95874 add-on applies to the professional fee component only in that scenario.
🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)
Note
Inpatient PCS coding for EMG-guided chemodenervation is uncommon — these patients are almost never admitted solely for this outpatient procedure. When PCS coding is encountered (e.g., during inpatient rehabilitation for spasticity management), the root operation is typically Introduction (injection of a therapeutic substance) within the Muscles body system. The EMG guidance component does not have a separate PCS root operation add-on — it is reflected in the approach character. PCS codes below represent the injection component; EMG guidance is implicit in the percutaneous approach.
| PCS Code | Full Description | Applicable Modality |
|---|---|---|
3E0K33Z | Introduction of Anti-inflammatory into Muscle, Percutaneous Approach | Botulinum toxin injection, upper extremity muscles — inpatient equivalence |
3E0M33Z | Introduction of Anti-inflammatory into Lower Muscle, Percutaneous Approach | Botulinum toxin injection, lower extremity / trunk muscles — inpatient equivalence |
PCS Character Analysis — 3E0K33Z
| Position | Character | Value | Definition |
|---|---|---|---|
| 1 | Section | 3 | Administration |
| 2 | Body System | E | Physiological Systems and Anatomical Regions |
| 3 | Root Operation | 0 | Introduction (putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance) |
| 4 | Body Part | K | Muscles |
| 5 | Approach | 3 | Percutaneous |
| 6 | Substance | 3 | Anti-inflammatory (botulinum toxin classified here in PCS) |
| 7 | Qualifier | Z | No Qualifier |
PCS Root Operation: Introduction vs. Measurement
- Use Introduction (0) when the inpatient procedure is the injection of botulinum toxin into muscle — this is the root operation for the chemodenervation component
- Use Measurement (0) under the Measurement and Monitoring section (Section 4) when the inpatient service is purely the diagnostic EMG assessment of muscle electrical activity (e.g.,
4A0F3EZ— Measurement of Musculoskeletal Electrical Activity, Percutaneous)- In practice, the EMG guidance for chemodenervation is not separately coded in PCS — it is inherent to the percutaneous approach character; assign a separate Measurement code only when a standalone diagnostic EMG study is performed and documented as a distinct service
📝 Coding Examples
Example 1 — Office: Cervical Dystonia, Single Session with EMG Guidance
Clinical Scenario: A 54-year-old female with a longstanding diagnosis of spasmodic torticollis (cervical dystonia) presents to the neurology clinic for her scheduled Botox injection cycle. The neurologist uses a Myoguide device to perform needle EMG guidance, confirming active motor unit potentials in the right splenius capitis and bilateral sternocleidomastoid muscles prior to injection. OnabotulinumtoxinA 200 units total is injected across three neck muscles. The procedure note documents: “Needle EMG guidance performed confirming correct placement in each target muscle prior to chemodenervation injection. EMG signal confirmed spontaneous motor unit activity in splenius capitis (right) and bilateral SCM before injection.” No separate E/M evaluation was documented.
| Field | Code | Rationale |
|---|---|---|
| CPT Primary | 64616-50 | Chemodenervation, neck muscle(s), excluding larynx — bilateral; -50 for bilateral same-session neck treatment |
| CPT Add-On | 95874 | Needle EMG guidance for chemodenervation — one unit per corresponding chemodenervation code; 64616 = one primary code, therefore one unit of 95874 |
| Drug | J0585 x 200 | OnabotulinumtoxinA (Botox®), per unit × 200 units administered |
| PDx | G24.3 | Spasmodic torticollis — specific billable code for cervical dystonia; links to both 64616 and 95874 |
Note
No modifier -25 is needed here because no separately documented E/M was performed. The pre-procedure assessment is bundled into the 64616 global (010-day) payment. If a new or unrelated problem was addressed at this visit, document it separately and append -25 to the E/M code.
Example 2 — Office: Multi-Extremity Spasticity, Bilateral Upper Limbs, with Separate E/M
Clinical Scenario: A 41-year-old male with spastic hemiplegia (right dominant side) following ischemic stroke presents to the PM&R clinic for quarterly Botox injections. The physiatrist performs a separately documented clinical assessment updating the spasticity rating scale (MAS) and reviewing functional goals — this constitutes a significant, separately identifiable E/M visit. Needle EMG guidance is used to confirm placement in the right flexor carpi radialis (1-4 muscles, right upper extremity) and right tibialis posterior (5+ muscles, right lower extremity). Two chemodenervation codes are reported.
| Field | Code | Rationale |
|---|---|---|
| CPT E/M | 99214-25 | Established patient office visit, moderate complexity — -25 on the E/M, not the procedure; documents separately identifiable evaluation for spasticity management review |
| CPT Primary 1 | 64642-RT | Chemodenervation, right upper extremity, 1-4 muscles; RT modifier for laterality |
| CPT Primary 2 | 64644-RT | Chemodenervation, right lower extremity, 5 or more muscles; RT modifier — NOTE: 64642 and 64644 reported for the same extremity; per CPT, only one primary extremity chemodenervation code per extremity — select the code matching the highest muscle count in that extremity (see pitfall #4 below) |
| CPT Add-On 1 | 95874 | EMG guidance for 64642 — 1 unit |
| CPT Add-On 2 | 95874 | EMG guidance for 64644 — 1 unit (one per corresponding chemodenervation code) |
| Drug | J0585 x 150 | OnabotulinumtoxinA units administered |
| PDx | G81.11 | Spastic hemiplegia, right dominant side — HCC 103 |
| SDx | I69.351 | Hemiplegia following cerebral infarction, right dominant side — supports etiology and HCC capture |
Warning
The -25 modifier belongs on the E/M code (99214-25), not on the procedure codes. A common audit finding is -25 appended to the chemodenervation or the guidance add-on code instead of to the E/M. Additionally, two separate E/M visits on the same day as chemodenervation require clear documentation that the evaluation addressed a problem beyond the standard pre-injection assessment.
Example 3 — Office: Pediatric Cerebral Palsy, Four-Extremity Chemodenervation, Units of 95874
Clinical Scenario: A 9-year-old male with spastic diplegic cerebral palsy (GMFCS Level III) presents to the pediatric PM&R clinic for botulinum toxin injections. The physiatrist performs EMG-guided chemodenervation of bilateral lower extremities — right lower extremity (5+ muscles: gastrocnemius, soleus, tibialis posterior, FHL, FDL) and left lower extremity (5+ muscles: same group). AbobotulinumtoxinA (Dysport®) is used. Documentation explicitly states needle EMG signal confirmed placement in each muscle prior to injection in all four muscle groups.
| Field | Code | Rationale |
|---|---|---|
| CPT Primary 1 | 64644-RT | Chemodenervation, right lower extremity, 5 or more muscles |
| CPT Add-On 1 | +64645-LT | Chemodenervation, each additional extremity, 5 or more muscles — left lower extremity (add-on to 64644) |
| CPT Guidance 1 | 95874 | EMG guidance for 64644 — 1 unit |
| CPT Guidance 2 | 95874 | EMG guidance for 64645 — 1 unit (second unit for the second chemodenervation code) |
| Drug | J0586 x [units] | AbobotulinumtoxinA (Dysport®), per 5 units — report total units administered |
| PDx | G80.1 | Spastic diplegic cerebral palsy — HCC 103 |
Note
Units of 95874: Two units are appropriate here because two chemodenervation codes were reported (64644 and 64645). The CPT rule is one unit of 95874 per corresponding chemodenervation code — no more, no less. If only one chemodenervation code had been reported, only one unit of 95874 would be billable regardless of how many muscles were injected or how many needle passes were made for EMG confirmation.
⚠️ Common Coding Pitfalls
-
Reporting more than one guidance code (95874 or 95873) per chemodenervation code: CPT explicitly instructs that only one guidance code may be reported per corresponding chemodenervation code. If you report 64642 once and 64644 once at the same session, the maximum billable guidance units are two — one per chemodenervation code. Reporting additional units of 95874 beyond the number of corresponding chemodenervation codes is overbilling and a high-frequency NCCI edit trigger.
-
Reporting 95874 with 64617 (larynx chemodenervation): CPT 64617 explicitly includes guidance by needle EMG when performed — do NOT separately report 95874 (or 95873) when the primary code is 64617. Doing so bills for a service already included in the 64617 descriptor and will result in claim denial or overpayment recoupment.
-
Reporting both 95874 and 95873 for the same chemodenervation code: These two guidance codes are mutually exclusive per CPT instruction — “do not report more than one guidance code for each corresponding chemodenervation code.” Report the modality actually used (needle EMG → 95874; electrical stimulation → 95873) and never both for the same procedure code on the same claim line.
-
Billing 95874 without a linked primary chemodenervation code: CPT 95874 is an add-on code and cannot stand alone. A claim submitted with only 95874 and no corresponding primary chemodenervation code will be denied. Always verify the primary code is present and correctly linked before billing the guidance add-on.
-
Using an unspecified ICD-10-CM without querying for specificity: Defaulting to R25.2 (cramp and spasm) when documentation clearly supports a specific neurological etiology (post-stroke hemiplegia, MS-related spasticity, cerebral palsy) misses HCC-eligible diagnoses and may not satisfy payer medical necessity criteria for chemodenervation. Query the provider or abstract from the record the specific underlying neurological diagnosis — the laterality, dominant vs. non-dominant side distinction (for G81.x codes), and etiology drive both HCC capture and prior authorization approval.
-
Applying modifier -51 to 95874: Add-on codes are modifier -51 exempt by definition. Never append -51 to any CPT code designated with the ”+” symbol. This is a coding error that incorrectly reduces reimbursement and is an easy audit flag.